Richard Hague
Directeur Général chez REGENETP, INC.
Fortune : 3 112 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Mark Lehman | M | - |
PolarityTE MD, Inc.
 PolarityTE MD, Inc. BiotechnologyHealth Technology PolarityTE MD, Inc. operates as a biotechnology company, which develops and commercializes regenerative tissue products and biomaterials. The company was founded on November 23, 2016 and is headquartered in Salt Lake City, UT. | - |
| Cheryl Blanchard | M | 59 | 6 ans | |
| Susan Vogt | F | 70 | 6 ans | |
| Ryan Mathis | M | - | 7 ans | |
| Jon Burrows | M | - | 5 ans | |
| James Chase | M | - | 6 ans | |
| Stephen Milner | M | - | 7 ans | |
| Nikolai Sopko | M | - | - | |
| Angela Ziegler | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| David Seaburg | M | 54 | 5 ans | |
| Denver M. Lough | M | 41 | 3 ans | |
| Jeffrey Dyer | M | 65 | 6 ans | |
| Joseph G. Darling | M | 66 | 3 ans | |
| Peter Cohen | M | 77 | 5 ans | |
| Charles Sherwood | M | 76 | 20 ans | |
| Cameron Hoyler | M | 40 | 10 ans | |
| Jon Mogford | M | 56 | 3 ans | |
| Minnie Baylor-Henry | F | 76 | 3 ans | |
| Willie Bogan | M | 75 | 5 ans | |
| Steven Gorlin | M | 87 | 2 ans | |
| Christian Nolet | M | 67 | 3 ans | |
| John C. Moran | M | 71 | 9 ans | |
| Steven E. Wheeler | M | 77 | 26 ans | |
| Ramses Erdtmann | M | 60 | 2 ans | |
| Jacob Patterson | M | 46 | 5 ans | |
| Jessica X. Shen | M | 60 | 2 ans | |
| Steven J. Chartier | M | 55 | 1 ans | |
| Robert Richard | M | - | 1 ans | |
| Alexei Goraltchouk | M | - | 3 ans | |
| Rich Haerle | M | - | 3 ans | |
| Caroline Garrett | M | - | 3 ans | |
| Thomas Finnerty | M | 66 | - | |
| Ellen MacKenzie | F | - | - | |
| Jennifer Burdman | F | - | 4 ans | |
| Stephen R. Mascioli | M | 69 | 1 ans | |
| Jean Bjerke | F | - | 1 ans | |
| Dana M. Alexander | M | 47 | 2 ans | |
| Christopher Ranjitkar | M | - | 1 ans | |
| Paul Mann | M | 48 | 2 ans | |
| Peter Stegagno | M | 63 |
Genzyme Biosurgery Corp.
 Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | 3 ans |
| Bill Densel | M | 56 |
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | 11 ans |
| James Mackin | M | 57 |
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | 8 ans |
| Edward Gaj | M | 67 | 4 ans | |
| Joseph M. Donabauer | M | 61 |
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | 3 ans |
| Francesco J. Luppino | M | 55 | 2 ans | |
| Ivy Estabrooke | M | 47 | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 46 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Richard Hague
- Réseau Personnel
